 |
 |
 |
 |
 |
 |
 |
 |
 |
"We are delighted to have Easton Hunt Capital Partners as an investor and strong
supporter of DepoMed. They are active advisors and welcome participants and contributors to our
Board discussions, especially on strategic growth issues. Importantly also, their connections in
the financial and biotech communities have proven quite beneficial for us as we continue to grow
DepoMed."
John Fara
CEO, DepoMed
DepoMed, Inc.
DepoMed (NASD: DEPO) is a drug delivery company developing new and proprietary oral delivery technologies to improve the performance of pharmaceutical products. DepoMed technology can provide pharmaceutical companies with a means of developing new and/or improved products and extending existing patent franchises.